Skip to content

Uterine Cycle and Menorrhagia

Peer reviewed Verified
Cite this article
AMA
MD A.. Uterine Cycle and Menorrhagia. My Endo Consult. Published January 11, 2025. Accessed October 18, 2026. https://myendoconsult.com/learn/topics/uterine-cycle-and-menorrhagia/
APA
MD A. (2025). Uterine Cycle and Menorrhagia. My Endo Consult. https://myendoconsult.com/learn/topics/uterine-cycle-and-menorrhagia/
Vancouver
MD A.. Uterine Cycle and Menorrhagia [Internet]. My Endo Consult; January 11, 2025 [cited October 18, 2026]. Available from: https://myendoconsult.com/learn/topics/uterine-cycle-and-menorrhagia/
BibTeX
@online{myendoconsult4422459,
  author = {Akuffo Quarde, MD},
  title  = {Uterine Cycle and Menorrhagia},
  organization = {My Endo Consult},
  year   = {2025},
  url    = {https://myendoconsult.com/learn/topics/uterine-cycle-and-menorrhagia/},
  urldate = {October 18, 2026}
}

INFLUENCE OF GONADAL HORMONES ON THE FEMALE REPRODUCTIVE CYCLE FROM BIRTH TO OLD AGE

General Overview

  • Primary gonadal hormones (estrogens, progestogens) maintain and nourish the reproductive tract and have widespread effects (skin, hair, skeleton, vascular, electrolytes, mood).
  • Ovarian secretions (chiefly estrogens) are crucial at every life phase: infancy, childhood, puberty, adult reproductive years, and senescence.

INFANCY

Newborn Estrogen Effects

  • High maternal estrogen crosses placenta → noticeable effects in the female neonate:
    • Breast enlargement (“witch’s milk” sometimes exuded).
    • External genitalia appear somewhat developed.
    • Endometrium stimulated to proliferate.
    • Vaginal epithelium: Stratified, cornified cells (estrogenic).
  • Regression After Birth:
    • Within ~1 week, these signs recede (low estrogen levels).
    • Newborn ovaries: small, containing only primordial follicles; cannot produce significant estrogens.

CHILDHOOD (Postnatal Recess to Pre-Puberty)

  1. Ovarian Changes
    • Gradual increase in interstitial tissue (fibrous stroma) as many follicles undergo atresia.
    • No functional follicular development capable of significant estrogen output.
  2. Vaginal Cytology
    • Shows predominantly basal/parabasal cells with bacteria/debris.
    • No estrogen-induced cornification.
  3. Breasts
    • Remain infantile (no glandular development).

PUBERTY (Sexual Maturation)

  1. Early Pubertal Changes
    • Uterus: First to respond to estrogens (endometrial proliferation with straight tubular glands).
    • Vagina: Thickens, becomes stratified; cornified cells in smears.
    • Ovarian Follicles: Progress beyond minimal layers → multiple granulosa layers, theca interna forming.
    • Breasts: Areola pigmentation; conical protuberance (thelarche).
    • Body Contours: Fat deposition (shoulders, hips, buttocks).
    • Hair: Adult pubic/axillary patterns begin.
  2. Gonadotropin-Ovarian Interplay
    • Pituitary FSH and LH must cycle appropriately with ovarian estrogen/progesterone to establish ovulatory cycles.
    • Adolescence and menopause can feature irregular, often anovulatory cycles.
  3. Menstrual Cycle Onset
    • Occurs with rhythmic ovulatory cycles after some months/years of initial irregularities.

ADULT REPRODUCTIVE YEARS

Mature Menstrual Cycle (28-day typical example)

  1. Menstrual Phase (days ~1–4)
    • Upper two-thirds of endometrium sloughed in 48–72 hrs.
    • Endometrial surface rapidly repaired under rising estrogen from developing follicles.
    • Vaginal smear: minimal estrogen effect.
  2. Follicular (Proliferative) Phase (days ~5–13)
    • Ovarian follicles develop under FSH → produce estrogen.
    • Endometrium thickens, glands elongate.
    • Vaginal epithelium: progressively cornified cells.
    • One follicle typically achieves dominance by ~day 12.
  3. Ovulation (day ~14)
    • LH surge triggers ovulation of mature follicle.
    • Rapid formation of corpus luteum → secretes progesterone (+some estrogen).
  4. Luteal (Secretory) Phase (days ~15–26)
    • Endometrial glands: sawtooth secretory changes under progesterone.
    • Vaginal smear: decreased superficial estrogenic cells, more folded intermediate cells (progesterone effect).
    • If no fertilization, corpus luteum regresses ~day 26 → drop in progesterone/estrogen.
  5. Premenstrual (days ~26–28)
    • Rapid hormone withdrawal → endometrium ischemic, breaks → menstruation day 28.

Additional Changes

  • Breasts: Fully mature, with duct extension (estrogen) + alveoli (progesterone).
  • Premenstrual Edema: Estrogen and progesterone can cause generalized fluid retention, recognized as bloating/weight gain.

Pregnancy

  1. Conception & Early Placental Hormones
    • Chorionic gonadotropin (hCG) from implanted embryo maintains corpus luteum → continued estrogen/progesterone production for first ~3 months.
    • Placenta takes over steroidogenesis after ~12 weeks.
  2. High, Increasing Estrogen & Progesterone → no new ovulation (FSH/LH suppressed).
  3. Breasts: Duct/alveolar proliferation (with pituitary prolactin); no full lactation until postpartum.
  4. Vaginal Cytology: High progesterone → “navicular cells” in smears.
  5. Puerperium: Post-delivery, large estrogen/progesterone withdrawal.
    • Prolactin + suckling reflex → lactation onset.
    • Ovarian cycles suppressed in lactation (varies from months to >1 year).

MENOPAUSE AND SENESCENCE

  1. Menopause:
    • Average ~51.4 years.
    • Ovaries lose functional follicles → low estrogen → high FSH (lack of negative feedback).
    • Physical changes: atrophy of breasts, uterus, vagina; bone loss; skin thinning; vasomotor symptoms.
  2. Premature Ovarian Failure:
    • Primary hypogonadism <40 years.
    • Similar changes to menopause.
  3. Senile Changes
    • Childhood and old age are relatively “quiet” gonadal phases.
    • Without sufficient estrogen, many tissues revert to atrophic states (bone loss, dryness).

FUNCTIONAL AND PATHOLOGIC CAUSES OF UTERINE BLEEDING

Normal Menstrual Bleeding

  1. Definition
    • The uterus is unique in undergoing cyclical necrosis and desquamation with bleeding as a healthy process.
    • Menstruation: Regular shedding of the superficial endometrium in response to rhythmic ovarian steroid (estrogen, progesterone) production.
  2. Characteristics
    • Typically 2–7 days duration, <80 mL total blood loss.
    • Regular cycles: Evidence of a well-ordered hormonal interplay (pituitary-ovarian-endometrial axis).

ABNORMAL UTERINE BLEEDING (Menorrhagia, Metrorrhagia)

Terminology

  • Menorrhagia: Heavy or prolonged menstrual flow.
  • Metrorrhagia: Bleeding at irregular intervals (spotting/bleeding between normal flows).

General Pathophysiologic Concepts

  1. Withdrawal Bleeding
    • Normal cycle: At end of luteal phase, corpus luteum regresses → drop in estrogen/progesterone → endometrial shedding.
  2. Anovulatory Cycles
    • Persistent estrogen production without ovulation → endometrium proliferates excessively.
    • Eventually, random estrogen dips or “breakthrough bleeding” occur, leading to unpredictable flow.
    • Common in adolescence, perimenopause, polycystic ovary syndrome (PCOS), weight loss, strenuous exercise, thyroid dysfunction, advanced liver/renal disease.
  3. Disordered Endometrial Responses
    • Mixed proliferative + secretory patterns (e.g., abnormal luteal phases).
    • Prolonged unopposed estrogen → endometrial hyperplasia; sporadic estrogen reduction triggers bleeding.

SPECIFIC CAUSES OF UTERINE BLEEDING

1. Non-Uterine Genital Tract Causes

  • Ovaries, Fallopian Tubes:
    • Ovarian cysts/tumors secreting hormones → abnormal bleeding.
  • Cervix, Vagina, Vulva, Urethra, Bladder, Bowel:
    • Cervical polyps, cervical cancer (often postcoital spotting, not heavy).
    • Traumas or fistulas from adjacent structures.

2. Local Uterine Pathologies

  • Polyps: Endometrial or cervical polyps.
  • Leiomyomas (Fibroids): Benign uterine smooth muscle tumors causing heavy/prolonged bleeding.
  • Adenomyosis: Endometrial tissue within the uterine muscle, leading to menorrhagia/dysmenorrhea.
  • Uterine Scar Defects: e.g., hysterotomy scar.
  • Malignancies:
    • Endometrial adenocarcinoma, uterine sarcoma, cervical cancer.
    • Metastatic disease to endometrium.
  • Uterine AVM (Arteriovenous Malformation): Rare cause of profuse bleeding.
  • Endometritis / PID: Infectious/inflammatory conditions.

3. Pregnancy-Related

  • Placenta Previa, Abruptio Placentae (premature separation), Spontaneous/Induced Abortions.
  • Ectopic Gestation: Implantation outside uterine cavity can present with bleeding.
  • Gestational Trophoblastic Disease: e.g., hydatidiform mole, choriocarcinoma.

4. Systemic Conditions

  • Bleeding Diatheses: e.g., von Willebrand disease, factor deficiencies, platelet function disorders.
  • Coagulopathy: e.g., advanced liver disease, or use of anticoagulants.
  • Acute Leukemia: Thrombocytopenia → abnormal uterine bleeding.
  • Endocrine Disorders: Hypothyroidism, hyperthyroidism, hyperprolactinemia, Cushing syndrome can cause menstrual irregularities.
  • Chronic Illness: e.g., advanced renal disease associated with anovulation.

KEY PHYSIOLOGIC PATHWAY

  1. Normal Cycle
    • Follicular Phase: Rising estrogen → endometrial proliferation.
    • Ovulation (LH surge) ~ day 14 (in a 28-day cycle).
    • Luteal Phase: Corpus luteum secretes progesterone (and some estrogen) → secretory changes in endometrium.
    • No Pregnancy: Hormones ↓ → endometrial ischemia → shedding (menstruation).
  2. Pathologic Bleeding arises from:
    • Hormonal Imbalance (e.g., anovulation, unopposed estrogen, suboptimal progesterone).
    • Uterine Structural Lesions (polyps, fibroids, adenomyosis).
    • Malignant/Pre-malignant changes (endometrial hyperplasia, carcinoma).
    • Pregnancy-Related or Systemic issues (bleeding disorders, endocrine pathology).